Analgesics: Regulation:Written question - 292368

Q
Asked by Helen Hayes
(Dulwich and West Norwood)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 30 September 2019
Department of Health and Social Care
Analgesics: Regulation
Commons
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of regulations on the (a) sale, (b) marketing and (c) proscribing of opioids and other extra strong pain relief medication.
A
Answered by: Ms Nadine Dorries
Answered on: 03 October 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has established an Opioid Expert Working Group under the auspices of the Commission on Human Medicines to examine current regulatory measures in place and whether further actions need to be taken.

This review is ongoing and has already recommended that labels of all opioid medicines should have prominent warnings on addiction on their packaging and identified that information for patients and healthcare professionals must be consistent and clear. The Expert Working Group is assessing access to opioid medicines available over the counter as well as by prescription.

Share this page